Related Experiment Video
Updated: Jun 5, 2026

Preparation of CD4+ T Cells for Analysis of GD3 and GD2 Ganglioside Membrane Expression by Microscopy
Published on: November 8, 2016
High-mobility group B1 (HMGB1) and receptor for advanced glycation end-products (RAGE) expression in canine lymphoma
Katharina A Sterenczak1, Alexa E Joetzke, Saskia Willenbrock
1Small Animal Clinic and the German Research Foundation SFB Transregio 37, University of Veterinary Medicine Hannover, 30559 Hannover, Germany.
Background:
Canine lymphoma is a commonly occurring, spontaneously developing neoplasia similar to human non-Hodgkin's lymphoma and, thus, is used as a valuable model for human malignancy. HMGB1 and RAGE are strongly associated with tumour progression and vascularisation. Consequently, deregulated RAGE and HMGB1 may play an important role in the mechanisms involved in lymphoma progression.
Materials And Methods:
Expression patterns of HMGB1 and RAGE were analysed in 22 canine lymphoma and three canine non-neoplastic control samples via real time PCR and canine beta-glucuronidase gene (GUSB) as endogenous control.
Results:
HMGB1 was up-regulated in the neoplastic samples, while RAGE expression remained inconspicuous.
Conclusion:
This study demonstrated similar mechanisms in lymphoma progression in humans and dogs due to overexpression of HMGB1, which was described in human lymphomas. RAGE remained stable in terms of expression indicating that the extracellular HMGB1-induced effects are regulated by HMGB1 itself.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Abnormal Proliferation
Proteoglycans
